Amyris (NASDAQ: AMRS)
Some price data may be temporarily unavailable.
Amyris Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Amyris Company Info
Amyris Inc. is building a renewable products company by applying its industrial synthetic biology technology platform to provide alternatives to select petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide.
News & Analysis
Why Amyris Stock Was Driven Into the Ground on Wednesday
To say that the company had a third quarter to forget is quite the understatement.
Why Amyris Stock Tumbled This Week
A new loan facility caused some consternation.
Biotech CEO: Synthetic Biology Will Revolutionize Beauty Care
It offers several interesting benefits.
Biotech CEO: We're Only Growing Stronger With AI, Robotics
They're also helping control costs.
Here's Why Amyris Stock Plunged 54% in November
The days grew shorter last month, as did investors' patience with this synthetic-biology specialist.
Why Shares of Amyris Are Plummeting This Week
There's nothing artificial about the plunging price of this synthetic biology stock.
Why Shares of Amyris Are Getting Crushed Today
Bears are turning their backs on this synbio stock today.
Never Mind Ginkgo Bioworks' Drama -- This Synthetic Biology Stock Is Still a Buy
If the latest short-seller attack on Ginkgo Bioworks has you nervous about synthetic biology, consider the industry leader.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.